Related Experiment Video

Updated: Jul 18, 2026

Tropomodulin 3 Overexpression as a Marker for Platinum Resistance and Immune Infiltration in Ovarian Cancer
09:40

Tropomodulin 3 Overexpression as a Marker for Platinum Resistance and Immune Infiltration in Ovarian Cancer

Published on: August 2, 2024

Activation of mitogen-activated protein kinases by cisplatin and their role in cisplatin-resistance

Anamaria Brozovic1, Maja Osmak

  • 1Rudjer Boskovic Institute, Division of Molecular Biology, Laboratory for Genotoxic Agents, Bijenicka 54, 10000 Zagreb, Croatia. brozovic@irb.hr <brozovic@irb.hr>

Cancer Letters
|November 28, 2006
PubMed

Insights

Mitogen-activated protein kinases (MAPKs) regulate gene expression and cell fate. This review explores their complex role in cellular responses to cisplatin and the development of resistance to this chemotherapy drug.

Area of Science:

  • Cellular Biology
  • Molecular Biology
  • Cancer Research

Background:

  • Mitogen-activated protein kinases (MAPKs) form a crucial intracellular signaling network controlling gene expression in response to external stimuli.
  • MAPKs regulate fundamental cellular processes including proliferation, differentiation, and cell death.
  • Three major MAPK pathways exist in mammals: SAPK/JNK, p38, and ERK, mediating distinct cellular responses.

Purpose of the Study:

  • To review the current understanding of MAPK involvement in cellular responses to cisplatin (cDDP).
  • To summarize the role of MAPKs in the development of resistance to cisplatin-based chemotherapy.
  • To elucidate the complex and cell-type-dependent functions of MAPKs in mediating cisplatin-induced apoptosis.

Main Methods:

  • Literature review of studies investigating MAPK signaling pathways.
  • Analysis of research on the impact of MAPK activation on cell fate following cisplatin treatment.
  • Examination of data linking MAPK activity to cisplatin resistance mechanisms.

Main Results:

  • MAPK activation is a key determinant of cell fate in response to cisplatin.
  • MAPKs can either induce or suppress apoptosis, with outcomes varying by cell type and tumor characteristics.
  • The role of MAPKs in cisplatin resistance is multifaceted and requires further investigation.

Conclusions:

  • MAPK signaling pathways play a critical role in how cells respond to cisplatin chemotherapy.
  • Understanding MAPK activation is essential for predicting treatment efficacy and overcoming cisplatin resistance.
  • Further research is needed to fully delineate the complex roles of different MAPK pathways in cancer therapy.

More Related Videos

Assessment of Mitochondrial Functions and Cell Viability in Renal Cells Overexpressing Protein Kinase C Isozymes15:43

Assessment of Mitochondrial Functions and Cell Viability in Renal Cells Overexpressing Protein Kinase C Isozymes

Published on: January 7, 2013

Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo09:19

Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo

Published on: February 6, 2015

Related Concept Videos

Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...